Clinical Trial Update: Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of temozolomide and lomustine followed by radiation therapy for high-grade malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumor

Drugs mentioned

• Gleostine (lomustine)
• Temodar (Temozolomide)

Snippet

Sponsor: Children's Oncology Group | Conditions: Brain Tumor, Central Nervous System Tumor | Phase 1 | Status: COMPLETED